ArticleJMIR medical informatics2021
Patient-Level Cancer Prediction Models From a Nationwide Patient Cohort: Model Development and Validation.
Article in JMIR medical informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 17 citations in OpenAlex.
- Machine learning-based gastric cancer risk prediction in an asymptomatic screening population: a retrospective cohort study.Journal of gastrointestinal oncology · 2026Article
- Convergence of machine learning and genomics for precision oncology.Nature reviews. Cancer · 2026Review
- Development and Validation of a Colorectal Cancer Prediction Model: A Nationwide Cohort-Based Study.Digestive diseases and sciences · 2024Article
- Random forest algorithm identifies miRNA signatures for breast cancer detection and classification from patient urine samples.Therapeutic advances in medical oncology · 2024Article
- Optimizing prognostic factors of five-year survival in gastric cancer patients using feature selection techniques with machine learning algorithms: a comparative study.BMC medical informatics and decision making · 2023Article
- Predicting Readmission Charges Billed by Hospitals: Machine Learning Approach.JMIR medical informatics · 2022Article
- Design and Development of an Intelligent System for Predicting 5-Year Survival in Gastric Cancer.Clinical Medicine Insights. Oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNationwide population-based cohorts provide a new opportunity to build automated risk prediction models at the patient level, and claim data are one of the more useful resources to this end. To avoid unnecessary diagnostic intervention after cancer screening tests, patient-level prediction models should be developed.
objectiveWe aimed to develop cancer prediction models using nationwide claim databases with machine learning algorithms, which are explainable and easily applicable in real-world environments.
methodsAs source data, we used the Korean National Insurance System Database. Every Korean in ≥40 years old undergoes a national health checkup every 2 years. We gathered all variables from the database including demographic information, basic laboratory values, anthropometric values, and previous medical history. We applied conventional logistic regression methods, light gradient boosting methods, neural networks, survival analysis, and one-class embedding classifier methods to effectively analyze high dimension data based on deep learning-based anomaly detection. Performance was measured with area under the curve and area under precision recall curve. We validated our models externally with a health checkup database from a tertiary hospital.
resultsThe one-class embedding classifier model received the highest area under the curve scores with values of 0.868, 0.849, 0.798, 0.746, 0.800, 0.749, and 0.790 for liver, lung, colorectal, pancreatic, gastric, breast, and cervical cancers, respectively. For area under precision recall curve, the light gradient boosting models had the highest score with values of 0.383, 0.401, 0.387, 0.300, 0.385, 0.357, and 0.296 for liver, lung, colorectal, pancreatic, gastric, breast, and cervical cancers, respectively.
conclusionsOur results show that it is possible to easily develop applicable cancer prediction models with nationwide claim data using machine learning. The 7 models showed acceptable performances and explainability, and thus can be distributed easily in real-world environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.